Skip to main content
. 2021 Aug 24;12:712351. doi: 10.3389/fimmu.2021.712351

Figure 4.

Figure 4

The timeline with therapy and disease status. HCC, hepatocellular carcinoma; TACE, transcatheter arterial chemoembolization; CR, complete response.